PE-22-28vs Selank The PE-22-28 peptide is emerging as a significant compound in neuroscience research, primarily recognized for its potential to mitigate depression and enhance cognitive function. As a synthetic derivative of spadin, a naturally occurring peptide, PE-22-28 acts as a potent inhibitor of the TREK-1 potassium channelPE 22-28 | TREK-1 Inhibitor. This specific action is central to its observed effects, including rapid antidepressant-like effects and the promotion of neurogenesisShortened Spadin Analogs Display Better TREK-1 Inhibition .... Research suggests that PE-22-28 may offer a novel therapeutic avenue for mood disorders and related neurological conditions.PE 22-28 (8mg) - peptide with antidepressant properties.
At its core, PE-22-28 functions by inhibiting the TREK-1 (TWIK-related acid-sensing ion channel family member 2) potassium channel. This channel is implicated in regulating neuronal excitability and plays a role in pain perception and moodPE 22-28 alsois a 7 amino-acid peptidethat is used as a core sequence for preparing analogs by chemical modifications and also by substitution of amino-acids.. By blocking TREK-1, PE-22-28 appears to modulate neuronal activity in a manner that leads to antidepressant effectsPE 22-28 is a TREK-1 inhibitor with IC 50 value of 0.12 nM. PE 22-28 also is a 7 amino-acid peptide that is used as a core sequence for preparing analogs.. Studies indicate that this inhibition can occur with a high potency, as evidenced by an IC50 value of 0PE-22-28 Peptide: Benefits, Dosage & Side Effects.12 nM.PE-22-28 Peptide: Benefits, Side Effects, and More This potent action is thought to be responsible for the rapid onset of its therapeutic benefits observed in preclinical models.
Beyond its TREK-1 inhibitory activity, PE-22-28 has demonstrated a capacity to significantly increase hippocampal neurogenesis and synaptogenesis. Neurogenesis, the birth of new neurons, and synaptogenesis, the formation of new connections between neurons, are critical processes for learning, memory, and overall brain health. The peptide's ability to promote these processes suggests a role in brain repair and resilience, potentially aiding in recovery from conditions like ischemia or stroke, where neuronal damage is a concern.
The research surrounding PE-22-28 peptide points to a multifaceted range of potential benefits, with a strong emphasis on mental health and cognitive enhancement.
* Antidepressant Properties: One of the most extensively studied applications of PE-22-28 is its potential as an antidepressantNovel lacto-peptides improve cognitive decline - PMC - NIH. Preclinical studies suggest that it can produce rapid antidepressant-like effects, potentially acting faster and with fewer side effects than some traditional antidepressant medications. This rapid action is attributed to its mechanism of modulating TREK-1 channels and promoting neurogenesisSpadin-analog specificity. (A–D) PE 22-28 was used as the....
* Cognitive Function Enhancement: The peptide has also shown promise in improving cognitive performance. By supporting neurogenesis and synaptogenesis, PE-22-28 may contribute to enhanced learning, memory, and overall brain plasticity.PE 22-28, a TREK-1 inhibitor exhibiting an IC50 value of 0.12 nM,is a 7 amino-acid peptide. It serves as a foundational sequence for the creation of analogs ... This makes it a subject of interest for research into cognitive decline and age-related memory issues.
* Stress Resilience and Anxiety Reduction: Emerging research indicates that PE-22-28 may play a role in enhancing stress resilience and reducing anxiety. Its influence on neuronal excitability and mood regulation suggests a broader impact on emotional well-being beyond just depression.
* Neuroprotection: In models of ischemia, PE-22-28 has been shown to reduce apoptotic cell death, indicating a neuroprotective effect. This suggests that the peptide could be beneficial in mitigating damage following events like stroke.
PE-22-28 is primarily a research peptide, meaning its applications are still under investigation in laboratory and preclinical settingsPE-22-28 Peptide | Memory & Brain Support - Paragon Sports Medicine. It is synthesized through processes like solid-phase peptide synthesis and is often made available at high purity levels for scientific research.Spadin-analog specificity. (A–D) PE 22-28 was used as the... The peptide's structure, described as a 7-amino-acid peptide, serves as a foundational sequence for creating various analogs through chemical modifications and amino acid substitutions. This allows researchers to explore structure-activity relationships and optimize its therapeutic potential.
While PE-22-28 is not an approved pharmaceutical drug for human use, its compelling preclinical data has generated significant interest. Researchers are exploring its efficacy in various behavioral models of depression and anxiety, as well as its impact on neuroplasticity. The development of PE-22-28 and its analogs represents an active area of research in the pursuit of novel treatments for neurological and psychiatric disorders.
Given its status as a research peptide, PE-22-28 should be handled with appropriate caution and used strictly for research purposes. Information regarding dosage protocols and potential side effects in humans is still largely based on preclinical data and expert clinical observations, rather than established pharmaceutical guidelines. The scientific community continues to investigate its long-term effects, optimal delivery methods (such as nasal spray formulations being explored), and precise mechanisms of action to fully understand its therapeutic profile and safety. As research progresses, PE-22-28 holds considerable promise for advancing our understanding and treatment of conditions affecting the brain and mood.
Join the newsletter to receive news, updates, new products and freebies in your inbox.